Vered Bisker-Leib, PhD

Vered Bisker-Leib, PhD has an extensive work experience in the biotechnology and pharmaceutical industry. Vered is currently serving as the President & Chief Operating Officer of Compass Therapeutics Inc. since August 2020. Prior to this role, they held positions of Chief Operating Officer, Chief Business Officer & Head of Finance and Operations, and Chief Business Officer in the same company.

In addition, they are a Board Member at Ayala Pharmaceuticals since August 2020. Previously, they co-founded Imara Inc. in 2016 and worked as an Entrepreneur-In-Residence at Atlas Venture from December 2016 to November 2017. Vered also served as the Chief Business Officer at Cydan Development, Inc. from October 2014 to November 2016.

Earlier in their career, Vered worked at Bristol-Myers Squibb, where they held various roles such as Executive Director of Business Development and Global Head, CV/Metabolics, Director of Strategic Transactions Group in Immunology, and Director of Strategic Transaction Group in Virology. Vered also worked as a Manager of Business Development at MedImmune from 2005 to 2007.

Vered Bisker-Leib, PhD, has a strong educational background in both Chemical Engineering and Management. Vered first attended the Technion - Israel Institute of Technology, where they earned a Bachelor of Science degree in Chemical Engineering from 1991 to 1995. Following this, Vered pursued further education at the University of Massachusetts Amherst, where they obtained a Ph.D. in Chemical Engineering from 1997 to 2002. During their time at UMass Amherst, Vered also pursued studies in Management at the Isenberg School of Management, obtaining an MBA from 1998 to 2001. Vered Bisker-Leib's primary field of study throughout their educational journey has been Chemical Engineering. There is one additional entry in their education history mentioning Ha' Reali, but no specific degree or field of study is provided.